Second Sight Medical Products
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Second Sight Medical Products sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Second Sight Medical Products: 4 sponsored US clinical trials, none currently recruiting.
Second Sight Medical Products sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is Blindness, Acquired, with 1 trials.
Upper-quartile sponsor footprint
Second Sight Medical Products sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
NCT03344848
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
NCT01860092
Argus® II Retinal Stimulation System Feasibility Protocol
NCT00407602
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
NCT00279500
Therapeutic Areas
How the Second Sight Medical Products archive is shaped
4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Blindness, Acquired (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Second Sight Medical Products: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Second Sight Medical Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Second Sight Medical Products page
4 registered trials is a research-attention snapshot, not an endorsement of Second Sight Medical Products or any single study.
- None of Second Sight Medical Products's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Blindness, Acquired is the condition Second Sight Medical Products studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Blindness, Acquired trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Second Sight Medical Products pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.